# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA701207 | F | Cytostatic activity against chronic myelogenous leukemia cells (K-562) based on its ability to inhibit [3H]thymidine incorporation; ND means not determined. | Homo sapiens | 3 | ALA1135898 | cell-based format | Scientific Literature | |
2. | ALA708913 | F | Percent inhibition of Mycobacterium tuberculosis H37Rv at 6.25 g/ml concentration in BACTEC 12B medium using microplate alamar blue assay | Mycobacterium tuberculosis | 20 | ALA1135898 | organism-based format | Scientific Literature | |
3. | ALA715912 | F | Antibacterial activity against Mycobacterium tuberculosis H37Rv in BACTEC 12B medium using microplate alamar blue assay;ND means not determined. | Mycobacterium tuberculosis | 13 | ALA1135898 | organism-based format | Scientific Literature | |
4. | ALA819510 | F | Minimum inhibitory concentration for testing cytotoxicity in VERO cells;ND means not determined. | Chlorocebus sabaeus | 12 | ALA1135898 | cell-based format | Scientific Literature | |
5. | ALA846457 | F | Selectivity Index, SI = IC50:MIC.ND means not determined. | 11 | ALA1135898 | assay format | Scientific Literature | ||
6. | ALA883168 | F | Cytotoxic concentration required to reduce the rRNA level of hepatitis C virus | Hepacivirus hominis | 21 | ALA1141079 | organism-based format | Scientific Literature | |
7. | ALA883725 | F | Effective concentration required to reduce Hepatitis C virus | Hepacivirus hominis | 21 | ALA1141079 | organism-based format | Scientific Literature | |
8. | ALA885022 | F | In vitro inhibitory concentration against mouse leukemia L1210 cell line | Mus musculus | 12 | ALA1141079 | cell-based format | Scientific Literature | |
9. | ALA885049 | F | In vitro inhibitory concentration against human cervix carcinoma HeLaS3 cell line | Homo sapiens | 10 | ALA1141079 | cell-based format | Scientific Literature | |
10. | ALA884039 | F | In vitro inhibitory concentration against human T lymphoblastoid CCRF-CEM cell line | Homo sapiens | 21 | ALA1141079 | cell-based format | Scientific Literature | |
11. | ALA884041 | F | In vitro inhibitory concentration against human promyelocytic leukemia HL60 cell line | Homo sapiens | 16 | ALA1141079 | cell-based format | Scientific Literature | |
12. | ALA899666 | F | Cytostatic activity against human CCRFCEM cells by MTT assay | Homo sapiens | 6 | ALA1137465 | cell-based format | Scientific Literature | |
13. | ALA899668 | F | Cytostatic activity against human HT1080 cells by MTT assay | Homo sapiens | 9 | ALA1137465 | cell-based format | Scientific Literature | |
14. | ALA899670 | A | Cytostatic activity against human WI38 cells MTT assay | Homo sapiens | 5 | ALA1137465 | cell-based format | Scientific Literature | |
15. | ALA1930345 | B | Activity of Escherichia coli PNP assessed per mg of protein at 100 uM by UV spectrometric analysis | Escherichia coli | 14 | ALA1926572 | assay format | Scientific Literature | |
16. | ALA1930346 | F | Cytotoxicity against human CCRF-CEM cells after 72 hrs by coulter counting | Homo sapiens | 11 | ALA1926572 | cell-based format | Scientific Literature | |
17. | ALA1930347 | F | Cytotoxicity against human SNB7 cells assessed as cell viability after 72 hrs by sulforhodamine B assay | Homo sapiens | 3 | ALA1926572 | cell-based format | Scientific Literature | |
18. | ALA1930348 | F | Cytotoxicity against human DLD1 cells assessed as cell viability after 72 hrs by sulforhodamine B assay | Homo sapiens | 3 | ALA1926572 | cell-based format | Scientific Literature | |
19. | ALA1930349 | F | Cytotoxicity against human ZR-75-1 cells assessed as cell viability after 72 hrs by sulforhodamine B assay | Homo sapiens | 3 | ALA1926572 | cell-based format | Scientific Literature | |
20. | ALA1930350 | F | Cytotoxicity against human NCI-H23 cells assessed as cell viability after 72 hrs by sulforhodamine B assay | Homo sapiens | 3 | ALA1926572 | cell-based format | Scientific Literature |